Clinical Trials Browser

Phase 2 × Recruiting × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT07047118 2026-03-02

A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 2 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04337580 2026-02-20

FASN

Phase 2 Recruiting

Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05393791 2024-11-26

ANZadapt

Phase 2 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant